Live Breaking News & Updates on Vir

Stay informed with the latest breaking news from Vir on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Vir and stay connected to the pulse of your community

Profund Advisors LLC Has $853,000 Position in Vir Biotechnology, Inc. (NASDAQ:VIR)

Profund Advisors LLC grew its stake in Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) by 51.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 91,038 shares of the company’s stock after acquiring an additional 31,029 shares during the quarter. Profund […]

China , Annm-hanly , Georgea-scangos , China-universal-asset-management-co , Profund-advisors , M-bidwell-associates-ltd , Nasdaq , Exchange-commission , Fifth-third-bancorp , Needham-company , Securities-exchange-commission

Vir Biotechnology (NASDAQ:VIR) Shares Down 2.7% After Insider Selling

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report)’s share price was down 2.7% on Tuesday after an insider sold shares in the company. The stock traded as low as $11.42 and last traded at $11.58. Approximately 140,465 shares changed hands during trading, a decline of 87% from the average daily volume of 1,121,850 shares. The […]

Georgea-scangos , Jpmorgan-chase-co , Barclays-plc , Vanguard-group-inc , Nasdaq , Securities-exchange-commission , Needham-company , Voloridge-investment-management , Vir-biotechnology-inc , Nuveen-asset-management , Vir-biotechnology

Shark Tank India 3: Namita Thapar's sons Jai and Vir grace the tank with their friends; happiest mom reacts |

Namita Thapar's sons Jai and Vir visit her on Shark Tank India 3 with their friends, making her the happiest mom. Namita is a powerful individual who appears on the business reality show as a Shark and is known for her great business concepts and investments in startups.

India , Vir-veeru , Vineeta-singh , Anupam-mittal , Aman-gupta , Namita-thapar , Amit-jain , Guidant-corporation , Shark-tank-india , Tank-india , Chartered-accountant , Vir

Vir Biotechnology (NASDAQ:VIR) Issues Quarterly Earnings Results

Vir Biotechnology (NASDAQ:VIR – Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.86) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.14) by $0.28, Briefing.com reports. Vir Biotechnology had a negative return on equity of 33.82% and a negative net margin of 713.69%. The business had […]

Georgea-scangos , Jpmorgan-chase-co , Vanguard-group-inc , Vir-biotechnology-inc , Geode-capital-management , Blackrock-inc , Needham-company , Securities-exchange-commission , Vir-biotechnology , Get-free-report , Exchange-commission

Vir Biotechnology (NASDAQ:VIR) Trading 8.5% Higher on Strong Earnings

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) rose 8.5% on Friday after the company announced better than expected quarterly earnings. The stock traded as high as $11.28 and last traded at $11.18. Approximately 290,356 shares changed hands during trading, a decline of 73% from the average daily volume of 1,084,488 shares. The stock had […]

Georgea-scangos , Perceptive-advisors , Nasdaq , Jpmorgan-chase-co , Securities-exchange-commission , Dimensional-fund-advisors , Vanguard-group-inc , Vir-biotechnology-inc , Needham-company , Norges-bank , Vir-biotechnology

Vir Biotechnology Chief Medical Officer Phil Pang to Depart

By Sabela Ojea Vir Biotechnology said Chief Medical Officer Phil Pang will be leaving the company at the end of March. The immunology company on Tuesday said...

Sabela-ojea , Chief-medical-officer-phil-pang , Article-normal , Biotechnology-services , Healthcare-life-sciences , Synd , Vir-biotechnology , Vir , Us92764n1028 , Healthcare , Life-sciences

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) has received a consensus rating of “Moderate Buy” from the seven brokerages that are covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price objective among brokerages […]

Jpmorgan-chase-co , Metlife-investment-management , Nasdaq , Needham-company , Blackrock-inc , Dimensional-fund-advisors , Vir-biotechnology-inc , Acadian-asset-management , Vir-biotechnology , Get-free-report , Asset-management

Vir Biotechnology (NASDAQ:VIR) Price Target Cut to $85.00

Vir Biotechnology (NASDAQ:VIR – Free Report) had its price objective trimmed by HC Wainwright from $95.00 to $85.00 in a research report report published on Tuesday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Vir Biotechnology’s Q1 2024 earnings at ($0.99) EPS, Q2 2024 […]

China , Needham-company , M-bidwell-associates-ltd , Vir-biotechnology-inc , Fifth-third-bancorp , Vir-biotechnology-company-profile , Third-bancorp , China-universal-asset-management-co , Vir-biotechnology , Free-report , Moderate-buy

Brokers Issue Forecasts for Vir Biotechnology, Inc.'s FY2028 Earnings (NASDAQ:VIR)

Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) – Analysts at HC Wainwright issued their FY2028 earnings per share (EPS) estimates for Vir Biotechnology in a report issued on Tuesday, January 23rd. HC Wainwright analyst P. Trucchio expects that the company will post earnings per share of ($0.56) for the year. HC Wainwright has a “Buy” […]

China , Needham-company , M-bidwell-associates-ltd , China-universal-asset-management-co , Nasdaq , Fifth-third-bancorp , Vir-biotechnology-inc , Third-bancorp , Vir-biotechnology , Free-report , Get-free-report

Viridium Pacific Group (CVE:VIR) Shares Up 5.6%

Viridium Pacific Group Ltd (CVE:VIR – Get Free Report)’s stock price shot up 5.6% during mid-day trading on Wednesday . The stock traded as high as C$0.41 and last traded at C$0.38. 26,500 shares were traded during trading, a decline of 71% from the average session volume of 92,632 shares. The stock had previously closed […]

Canada , Viridium-pacific-group-ltd , Viridium-pacific-group-trading , Viridium-pacific-group , Viridium-pacific-group-company-profile , News-ratings-for-viridium-pacific-group-daily , Get-free-report , Pacific-group-ltd , Viridium-pacific-group-daily , Cve-vir , Vir